Stockreport

CareDx to acquire Naveris in up to $260M oncology diagnostics deal [Seeking Alpha]

CareDx, Inc.  (CDNA) 
Last caredx, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.caredxinc.com
PDF Naveris, which develops blood-based tests for viral-mediated cancers, reported unaudited revenue of about $34 million in 2025. CareDx said the deal is expected to be [Read more]